Trials / Unknown
UnknownNCT04005365
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Efficacy and Safety of Propranolol Combined With Neoadjuvant Chemotherapy in Stage III-IV Gastric Cancer: an Open-lable, Single-arm Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- Yijing He · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
At the cellular and animal level, we found that propranolol can inhibit the proliferation and invasion of gastric cancer cells. Further, we want to explore the efficacy and safety of propranolol in the treatment of gastric cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | add propranolol in gastric cancer patients who need to receive preoperate chemotherapy |
Timeline
- Start date
- 2019-11-20
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2019-07-02
- Last updated
- 2019-11-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04005365. Inclusion in this directory is not an endorsement.